Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of June 2026
Apple Boston @Apple Boston
Brass member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,228,556talents

Virtual portfolio value:

$5,124,940talents

Net overall return per annum:

18.78%

AYA current rank order:

#18

Asset investment philosophy:
Apple Boston trades U.S. stocks with the top #226 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
UBXG U-BX Technology Ltd. Class A Ordinary Shares $0.34 $3.98 38,608 +1,070.59% $140,533
UMAC Unusual Machines Inc. Common Stock $1.87 $18.73 7,019 +901.60% $118,340
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 80,273 +793.33% $95,525
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 11,933 +2,108.33% $90,571
VATE INNOVATE Corp. Common Stock $0.53 $4.14 22,718 +681.13% $82,012
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 629 +601.88% $70,379
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 1,509 +589.24% $61,975
HZNP Horizon Therapeutics Public Limited Company Ordinary Shares $16.41 $98.56 640 +500.61% $52,576
TUEM Tuesday Morning Corp. Common Stock $0.12 $0.69 90,033 +475.00% $51,319
MRNS Marinus Pharmaceuticals Inc. Common Stock $1.94 $11.62 3,749 +498.97% $36,290
Sum $799,520

Top 10 current stock portfolio positions as of June 2026Strategy

Symbol Company Price Position Capitalization
NVCT Nuvectis Pharma Inc. Common Stock $28.53 1,744 $49,756
MBX MBX Biosciences Inc. Common Stock $53.85 540 $29,079
QURE uniQure N.V. Ordinary Shares $47.39 596 $28,244
APGE Apogee Therapeutics Inc. Common Stock $132.61 207 $27,450
AMAT Applied Materials Inc. Common Stock $694.64 37 $25,701
MAMA Mama's Creations Inc. Common Stock $20.65 1,232 $25,440
SI Shoulder Innovations Inc. Common Stock $21.09 1,157 $24,401
BBNX Beta Bionics Inc. Common Stock $17.00 1,403 $23,851
ZBIO Zenas BioPharma Inc. Common Stock $25.55 924 $23,608
TECH Bio-Techne Corp Common Stock $70.90 329 $23,326
Sum $280,856

Top 20 influencers

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$NVDA $AAPL
$TSLA $META
$GOOG
$AMZN
$MSFT

Blog+More

Fed Chair Jerome Powell increases the neutral interest rate to a range of 1.5% to 1.75% in his debut press conference.

Chanel Holden

2018-03-21 06:32:00 Wednesday ET

Fed Chair Jerome Powell increases the neutral interest rate to a range of 1.5% to 1.75% in his debut press conference.

Fed Chair Jerome Powell increases the neutral interest rate to a range of 1.5% to 1.75% in his debut post-FOMC press conference. The Federal Reserve raises

+See More

Federal Reserve reduces the interest rate by another quarter point to the target range of 1.75%-2% in September 2019.

John Fourier

2019-10-07 12:35:00 Monday ET

Federal Reserve reduces the interest rate by another quarter point to the target range of 1.75%-2% in September 2019.

Federal Reserve reduces the interest rate by another key quarter point to the target range of 1.75%-2% in September 2019. In accordance with the Federal Res

+See More

Michael Bloomberg criticizes that the Trump administration's tax reform is a trillion dollar blunder.

Fiona Sydney

2017-12-09 08:37:00 Saturday ET

Michael Bloomberg criticizes that the Trump administration's tax reform is a trillion dollar blunder.

Michael Bloomberg, former NYC mayor and media entrepreneur, criticizes that the Trump administration's tax reform is a trillion dollar blunder because i

+See More

Angus Deaton analyzes the correlation between health and wealth in light of the economic origins of inequality worldwide.

James Campbell

2023-04-21 12:39:00 Friday ET

Angus Deaton analyzes the correlation between health and wealth in light of the economic origins of inequality worldwide.

Angus Deaton analyzes the correlation between health and wealth in light of the economic origins of inequality worldwide. Angus Deaton (2015)  

+See More

Agile business firms beat the odds by building faster institutional reflexes to anticipate plausible economic scenarios.

Fiona Sydney

2020-09-03 10:26:00 Thursday ET

Agile business firms beat the odds by building faster institutional reflexes to anticipate plausible economic scenarios.

Agile business firms beat the odds by building faster institutional reflexes to anticipate plausible economic scenarios. Christopher Worley, Thomas Willi

+See More

Colin Camerer, George Loewenstein, and Matthew Rabin assess the recent advances in the behavioral economic science.

James Campbell

2023-09-14 09:28:00 Thursday ET

Colin Camerer, George Loewenstein, and Matthew Rabin assess the recent advances in the behavioral economic science.

Colin Camerer, George Loewenstein, and Matthew Rabin assess the recent advances in the behavioral economic science. Colin Camerer, George Loewenstei

+See More